Sacroiliitis
Conditions
Keywords
Sacroillitis, Triamcinolone
Brief summary
Sacroiliitis is a common cause of low back and buttock pain. Intra-articular steroid injection of the sacroiliac joint can provide pain relief and functional improvement. This randomized controlled trial aims to compare the outcomes of ultrasound-guided versus fluoroscopic-guided sacroiliac joint steroid injections in patients with sacroiliitis. The study will evaluate procedural success, pain reduction, and functional improvement using the Visual Analogue Scale (VAS) and Oswestry Disability Index (ODI) at follow-up intervals.
Detailed description
The sacroiliac joint (SIJ) is increasingly recognized as a contributor to low back pain (LBP), with epidemiological estimates attributing approximately 10-30 % of mechanical low back pain cases to SIJ pathology1. Anatomically, the SIJ is a synovial-type (inferior portion) or syndesmosis-type (superior portion) joint between the sacrum and the ilium, supported by substantial interosseous, posterior and anterior ligaments and innervated by dorsal sacral rami and lower lumbar dorsal rami2. Inflammatory involvement of the SIJ occurs in conditions such as axial spondyloarthritis and may also arise post-traumatically or degeneratively3. NSAIDs and physical therapies are used to treat sacroiliitis. However, intraarticular corticosteroid injections administered locally to the SI joint might result in rapid and significant clinical improvements in extremely painful instances4,5. Fluoroscope guided (FL) is usually employed to increase the precision of this treatment, however CT and MRI have also been used in recent years. These imaging techniques have a number of drawbacks, such as radiation exposure, expense, and the need for suitable infrastructure6. A new alternative technique for guiding SIJ injection is ultrasound (US) guidance. The advantages of US-guided injection over FL include that it eliminates radiation exposure, is more accessible, and is less expensive when used alone. Additionally, the US permits "real-time" visualisation of the injectate distribution and needle tip during injection.7,8.
Interventions
Participants will receive intra-articular sacroiliac joint steroid injection under ultrasound guidance. A needle will be advanced under real-time ultrasound guidance to the sacroiliac joint, and 40 mg triamcinolone acetonide mixed with 1 mL 0.25% bupivacaine will be injected.
Sponsors
Study design
Intervention model description
Participants will be randomly assigned in a 1:1 ratio to receive intra-articular sacroiliac joint steroid injection either under ultrasound guidance or fluoroscopic guidance. Outcomes will be compared between both groups.
Eligibility
Inclusion criteria
* Age 18-70 years * Both sexes * Clinical diagnosis of sacroiliitis
Exclusion criteria
* Prior SI joint injection in the past 12 months * Contraindication to corticosteroid injection (systemic infection, local infection, bleeding diathesis, uncontrolled diabetes with HbA1c \>9%, allergy to contrast or steroid) * Radicular or neurogenic pain attributable to lumbar spine or hip pathology * Pregnancy or breastfeeding * Severe osteoarthritis or fusion of the SI joint on imaging * Systemic rheumatologic disease requiring systemic biologic therapy (unless stable for \>6 months)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Procedural success rate of sacroiliac joint injection | During the procedure | Successful intra-articular deposition of steroid in the sacroiliac joint confirmed by the respective imaging guidance modality (ultrasound or fluoroscopy). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Oswestry Disability Index (ODI) Score | Baseline, 2 weeks, 1 month, and 3 months after the procedure | Successful intra-articular deposition of steroid in the sacroiliac joint confirmed by the respective imaging guidance modality (ultrasound or fluoroscopy). |
Countries
Pakistan